Nano-bioparticles: Fighting cancer with targeted nanotherapy
Dr. LK Medina-Kauwe developed a bioengineered delivery system to treat resistant and metastatic tumors, highlighting nano-bioparticles.
Repurposing parts of viruses, growth factors, and nucleic acid-binding proteins has led to the development of a bioengineered therapeutic delivery vehicle being evaluated as a cancer-specific molecular missile.
Dr LK Medina-Kauwe combined the cell-binding, membrane-penetration, and intracellular trafficking functions of pathogen proteins and naturally occurring protein ligands to develop a biologically based tumor-homing platform technology designed to self-assemble with and selectively deliver therapeutic molecules to resistant and metastatic tumors.
These molecular missiles are comprised of nano-sized biologically derived particles, or nano-bioparticles (NBPs).
Author summary: Targeted nanotherapy fights cancer with nano-bioparticles.
More News
- Trump Serenaded With Anthem YMCA as He Lands in South Korea
- Record Job Cuts at Amazon and UPS. AI and Reorganization Changing the Face of Logistics
- Trump Goes Full Dictator With Bonkers Threat to Use Air Force and Navy in U.S. Cities
- Understanding the Different Types of Attic Insulation: Which One Works Best for Your Home? - GigWise
- Formula E's Women's Test is back: will it lead to real change on the grid?